{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "priceEpsCurrentYear": -4.928571, "sharesOutstanding": 69637504, "bookValue": 0.477, "fiftyDayAverage": 0.62996, "fiftyDayAverageChange": 0.060039997, "fiftyDayAverageChangePercent": 0.09530763, "twoHundredDayAverage": 0.720955, "twoHundredDayAverageChange": -0.030955017, "twoHundredDayAverageChangePercent": -0.042936128, "marketCap": 51551488, "forwardPE": -2.6538463, "priceToBook": 1.4465408, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "exchange": "NCM", "shortName": "Medicenna Therapeutics Corp.", "longName": "Medicenna Therapeutics Corp.", "messageBoardId": "finmb_245978917", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": -1.9329153, "regularMarketPrice": 0.69, "firstTradeDateMilliseconds": 1510583400000, "priceHint": 4, "regularMarketChange": -0.013599992, "regularMarketTime": 1684180798, "regularMarketDayHigh": 0.7303, "regularMarketDayRange": "0.69 - 0.7303", "regularMarketDayLow": 0.69, "regularMarketVolume": 68587, "regularMarketPreviousClose": 0.7036, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 8, "fullExchangeName": "NasdaqCM", "financialCurrency": "CAD", "regularMarketOpen": 0.7148, "averageDailyVolume3Month": 75223, "averageDailyVolume10Day": 79790, "fiftyTwoWeekLowChange": 0.29299998, "fiftyTwoWeekLowChangePercent": 0.7380352, "fiftyTwoWeekRange": "0.397 - 1.88", "fiftyTwoWeekHighChange": -1.19, "fiftyTwoWeekHighChangePercent": -0.63297874, "fiftyTwoWeekLow": 0.397, "fiftyTwoWeekHigh": 1.88, "earningsTimestamp": 1675776600, "earningsTimestampStart": 1687264200, "earningsTimestampEnd": 1687782600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.11, "epsForward": -0.26, "epsCurrentYear": -0.14, "displayName": "Medicenna Therapeutics", "symbol": "MDNA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2 Bloor Street West", "address2": "7th Floor", "city": "Toronto", "state": "ON", "zip": "M4W 3E2", "country": "Canada", "website": "https://www.medicenna.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Fahar  Merchant Ph.D.", "age": 65, "title": "Founder, Chairman, Pres & CEO", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 338301, "fmt": "338.3k", "longFmt": "338,301"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Rosemina  Merchant B.Sc., M.E.Sc", "age": 65, "title": "Founder, Chief Devel. Officer & Director", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 271294, "fmt": "271.29k", "longFmt": "271,294"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elizabeth  Williams C.A., CPA, CA, CPA", "age": 44, "title": "CFO & Corp. Sec.", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 227655, "fmt": "227.66k", "longFmt": "227,655"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Martin  Bexon M.D., MBBS", "title": "Acting Chief Medical Officer & Head of Clinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Samuel R. Denmeade M.D.", "title": "Scientific Advisor", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 7, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}